Annamycin given Fast Track Designation in the US for the treatment of sarcoma lung metastases

Annamycin is a next generation anthracycline under investigation which accumulates specifically in the lungs as compared to doxorubicin, and has a potential for reduced cardiotoxicity.

Source:

Biospace Inc.